Neoleukin Therapeutics
+$0.02 (+0.16%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours
Why Robinhood?
You can buy or sell NLTX and other stocks, options, and ETFs commission-free!
About NLTX
Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.
CEO
Jonathan G. Drachman
Employees
70
Headquarters
Seattle, Washington
Founded
2003
Market Cap
519.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
154.36K
High Today
$12.85
Low Today
$12.21
Open Price
$12.38
Volume
251.09K
52 Week High
$18.13
52 Week Low
$9.63
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
NLTX Earnings
-$0.44
-$0.29
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours